Sleep-Wake Disorders Notes
Overview of Sleep-Wake Disorders
Sleep-wake disorders represent a collection of common and often debilitating conditions that significantly disrupt an individual's sleep patterns and overall functioning.
These disorders are not merely inconvenient; they contribute to a wide array of negative outcomes, including:
Emotional distress: Leading to anxiety, depression, and irritability.
Social or occupational dysfunction: Impairing relationships, work performance, and academic success.
Increased risk for injury: Due to impaired alertness, such as drowsy driving accidents.
Serious medical illnesses: Exacerbating existing conditions or increasing the risk for new ones, like cardiovascular disease or diabetes.
Importance of Sleep Disturbances
Historically, sleep disturbances were often viewed solely as common symptoms of various psychopathological conditions (e.g., insomnia as a symptom of depression).
Their significance as independent clinical entities, capable of existing on their own and requiring specific treatment, was frequently minimized or neglected by mental health professionals and other health care providers.
Over the past three decades, a substantial and growing body of research has profoundly highlighted the importance of sleep-wake disorders as primary disorders. This research demonstrates that these disorders can occur:
In isolation: As a standalone diagnosis, independent of other mental or medical conditions.
Comorbidly with other mental and medical disorders: Where they exist alongside other conditions, often exacerbating or complicating them. This understanding has shifted the paradigm towards recognizing sleep-wake disorders as critical targets for diagnosis and treatment.
Classification of Sleep-Wake Disorders
Nosological Development
The systematic classification systems (nosologies) for diagnosing sleep-wake disorders are relatively new, having been available for only about the past four decades.
During this period, several divergent approaches to classify these disorders have been proposed. However, the reliability (consistency of diagnosis) and validity (accuracy of diagnosis) of these early classifications have often been limited, making consistent diagnosis and research challenging.
Diagnostic Classification of Sleep and Arousal Disorders (DCSAD)
The first formal classification system, published in 1979 by the Association of Sleep Disorders Centers (ASDC).
This classification primarily categorized disorders based on patients' predominant presenting complaints, which helped in clinical recognition. It included:
Disorders of Initiating and Maintaining Sleep (DIMS):
This category specifically addressed issues related to insomnia. It included seven distinct insomnia subtypes, which were understood to arise from psychiatric, behavioral, or medical causes.
Disorders of Excessive Daytime Sleep (DOES):
This category was specifically reserved for sleep-wake disturbances where the primary complaint was excessive daytime sleepiness (EDS), indicating problems with staying awake rather than falling asleep.
Sleep-Wake Schedule Disorders:
These conditions arise from a significant mismatch between an individual's natural, internal biological clock (endogenous circadian rhythms) and their desired or imposed sleep-wake schedules (e.g., the disruption common with jet lag across time zones or shift work).
Parasomnias:
This category encompassed unusual or undesirable physical events or experiences that occur before, during, or after sleep. Examples include unusual events like nocturnal seizures or aberrant behaviors such as sleep-walking, night terrors, or sleep-talking.
ICD-9 and DSM Classifications
ICD-9 (International Classification of Diseases, 9th Revision):
Provided a global nosology (systematic classification) that listed sleep disorders. They were largely categorized by their presumed origin:
Nonorganic origin: Sleep disorders primarily due to psychological or behavioral factors.
Organic origin: Termed "true" primary sleep disorders, implying a physiological basis.
DSM-III-R (Diagnostic and Statistical Manual of Mental Disorders, Third Edition - Revised):
This version included 15 distinct diagnoses related to sleep-wake disorders.
Its classification for insomnia was more refined, recognizing different etiologies:
Insomnia due to another mental disorder: Where insomnia was clearly a symptom of a coexisting psychiatric condition.
Insomnia due to a known organic factor: When a medical condition or substance use was the direct cause.
Primary insomnia: Insomnia existing independently, without being secondary to other conditions.
Insomnia not otherwise specified: For presentations that didn't fully meet other criteria.
Other specific diagnoses included breathing-related sleep disorders, narcolepsy, primary hypersomnia, and more.
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition):
This version grouped sleep disorders based on their underlying pathophysiology (the functional changes associated with disease).
It included 22 distinct disorders, which were presumed to be categorized as either:
Primary sleep-wake disorders: Disorders that arise intrinsically from sleep-generating mechanisms.
Predominantly secondary symptoms from other psychiatric or medical disorders: Where sleep disturbance was a symptom or consequence of another primary condition.
DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition):
Represented a significant transition in classification, moving from distinct types of sleep disorders to more general categories.
This allowed for diagnoses even in complex cases where other medical, psychiatric, or other sleep disorders are present concurrently.
It emphasized eight global categories, focusing on core patient experiences and complaints:
Patient dissatisfaction with sleep function: Reflecting subjective sleep quality.
Daytime sleepiness or impairment: Highlighting the functional consequences during waking hours.
Unusual behaviors during sleep: Encompassing parasomnias and other abnormal nocturnal activities.
Insomnia Disorder
Diagnostic Criteria
The predominant complaint is a significant dissatisfaction with sleep quantity or quality, specifically associated with one or more of the following symptoms:
Difficulty initiating sleep: Trouble falling asleep at bedtime. (In children, this may manifest as needing significant caregiver intervention to initiate sleep).
Difficulty maintaining sleep: Characterized by frequent awakenings throughout the night or problems returning to sleep after waking. (Again, in children, this may require caregiver intervention).
Early-morning awakenings with an inability to return to sleep: Waking up much earlier than desired and being unable to fall back asleep.
These sleep disturbances cause clinically significant distress or impairment in important areas of functioning (e.g., social, occupational, educational, behavioral).
The sleep difficulty occurs at least three nights per week.
The problem has been present for at least three months.
The sleep difficulty occurs despite adequate opportunity for sleep (i.e., the individual has enough time allotted for sleep but cannot achieve it).
The insomnia is not better explained by another sleep-wake disorder (e.g., narcolepsy, breathing-related sleep disorders).
The symptoms are not attributable to the physiological effects of substances (e.g., drugs of abuse, medications).
Coexisting mental and medical conditions do not adequately explain the predominant complaint of insomnia (i.e., the insomnia is not solely a symptom of another condition).
Characteristics
Insomnia disorder is specifically marked by chronic dissatisfaction with sleep quantity or quality.
A crucial aspect is its ability to occur:
Independently: As a primary problem not caused by another disorder.
Comorbidly with psychiatric, medical, substance use, or another sleep disorder: Where it coexists with other conditions. In such cases, insomnia can be both a symptom and an independent issue, often requiring its own specific treatment.
Significant comorbid insomnia, even if not meeting full criteria for another mental disorder, may present with symptoms such as moderate anxiety, mood disturbances, concentration issues, memory dysfunction, and general malaise. This highlights its broad impact on well-being.
In cases of comorbid conditions, insomnia symptoms may initially emerge due to the comorbid condition (e.g., depression-related insomnia) but later develop independency, meaning they persist even if the primary comorbid condition improves.
Problematic Sleep Patterns
The core sleep symptoms of insomnia disorder include:
Difficulty initiating sleep (difficulty falling asleep).
Difficulty maintaining sleep, often characterized by frequent awakenings or trouble returning to sleep after waking.
Waking prematurely (early-morning awakenings) without the ability to return to sleep.
Clinical observations suggest that difficulties maintaining sleep are generally more common than issues primarily with initiating sleep.
It's important to note that specific sleep complaints can change over time within the same individual, meaning a person might present with difficulty initiating sleep at one point and then later primarily with early awakenings.
Epidemiological Data
Insomnia is a widespread concern, and its complaints are often age-related, with a higher prevalence among middle-aged and older adults.
Conversely, sleep-onset difficulties (trouble falling asleep) tend to be more common in young adults.
Insomnia complaints are generally more prevalent among women. This could be due to actual biological or social sex differences, or potentially due to reporting bias (women being more likely to report symptoms).
It is reported that a significant portion of the adult population, approximately 9\% to 22\% may experience some form of chronic insomnia complaints.
However, a narrower subset, between 6\% and 10\% of adults, meets the full, rigorous DSM diagnostic criteria for insomnia disorder.
Etiology
Spielman Model (1986): Also known as the 3-P model (predisposing, precipitating, perpetuating), this widely accepted cognitive-behavioral model attributes insomnia to a complex interaction of factors:
Endogenous predisposing characteristics: These are long-standing vulnerabilities or traits that make an individual more prone to developing insomnia. Examples include a genetic predisposition, a tendency towards worry or rumination, physiological hyperarousal (being easily agitated), or repression of emotions.
Sleep-disruptive precipitating events: These are acute stressors or life events that trigger an episode of insomnia. Examples include the loss of a loved one, significant medical procedures, job stress, or major life changes. While these events initiate the insomnia, they typically resolve over time.
Perpetuating behaviors or environmental cues: These are factors that maintain the insomnia despite the initial precipitating event having passed. They include conditioned cues and sleep-disruptive habits. For instance, spending too much time in bed awake (conditioning the bed as a place for wakefulness), consistent napping, irregular sleep schedules, or excessive caffeine intake can all perpetuate insomnia. These behaviors prevent natural sleep recovery.
Clinical observations strongly substantiate this model, highlighting how heightened preoccupations with sleep (anxiety about not sleeping) and pre-sleep rituals (checking the clock, trying too hard to sleep) can inadvertently exacerbate and maintain insomnia over time.
Hypersomnolence Disorder
Diagnostic Criteria
The core feature is a self-reported excessive sleepiness (hypersomnolence) despite having achieved a main sleep period of at least seven hours. This excessive sleepiness is manifested by at least one of the following:
Recurrent periods of sleep or lapses into sleep within the same day: Despite nocturnal sleep, the individual experiences an irresistible need to sleep during waking hours.
A prolonged main sleep episode (> 9 hours) that is nonrestorative: Even with extended nocturnal sleep, the individual does not feel refreshed or adequately rested.
Difficulty becoming fully awake after an abrupt awakening: Known as "sleep inertia," this involves prolonged grogginess and impaired performance immediately after waking.
The excessive sleepiness occurs at least three times per week for at least three months, leading to significant functional impairment (e.g., at work, school, or socially).
The hypersomnolence is not better explained by another sleep disorder (e.g., narcolepsy, sleep apnea) or attributable to the physiological effects of substances (e.g., medications, drugs of abuse).
Characteristics and Prevalence
Hypersomnolence Disorder, often also referred to as idiopathic hypersomnia, is characterized by persistent and overwhelming excessive daytime sleepiness even when individuals obtain what appears to be adequate or even prolonged nocturnal sleep.
Key symptoms include persistently prolonged non-refreshing sleep, significant difficulty awakening from sleep (sleep inertia), and recurrent, often irresistible, lapses into sleep during the day.
It is estimated that approximately 2\% to 5\% of adults meet the criteria for this disorder.
The onset is common in late adolescence and young adulthood, and the disorder is often chronic and can be resistant to treatment efforts.
Narcolepsy
Diagnostic Criteria
Narcolepsy is a chronic neurological condition characterized by irrepressible attacks of daytime sleepiness. The diagnostic criteria include:
Recurrent periods of an irrepressible need to sleep, lapsing into sleep, or napping occurring within the same day: This must occur at least three times weekly over the past three months.
In addition to the above, at least one of the following hallmark features must be present:
Episodes of cataplexy: This is a sudden, brief loss of muscle tone while remaining conscious, typically triggered by strong emotions such as laughter, anger, or excitement. It can manifest as sagging facial muscles, slurred speech, or even a complete collapse.
Hypocretin deficiency: Indicated by low levels of hypocretin-1 (also known as orexin) in the cerebrospinal fluid ( \le 110 pg/mL or less than one-third of mean values obtained in healthy individuals). Hypocretin is a neuropeptide that plays a crucial role in regulating wakefulness.
REM sleep latency of less than or equal to 15 minutes: This is observed during a nocturnal polysomnography, or a mean sleep latency of less than or equal to 8 minutes and two or more sleep-onset REM periods (SOREMPs) on a multiple sleep latency test (MSLT).
Narcolepsy was historically first described in 1880 by neurologist Jean-Baptiste Gélineau as a syndrome characterized by irresistible daytime sleep episodes, often paired with sudden falls (which would later be identified as cataplexy).
Symptomatology
Narcolepsy is commonly associated with a 'tetrad' of classic symptoms, though not all individuals experience all four:
Excessive Daytime Sleepiness (EDS): The primary and most debilitating symptom, involving persistent and overwhelming sleepiness during the day, often leading to unintended sleep episodes even in inappropriate situations.
Cataplexy: As described above, this is an acute, sudden loss of muscle tone while remaining fully conscious, almost always triggered by strong emotional stimuli (e.g., laughter, anger, surprise). It can range from mild weakness to complete body collapse.
Sleep paralysis: A temporary inability to move or speak upon awakening (either from nocturnal sleep or a nap) or during sleep onset. The individual is conscious but cannot control their body.
Hypnagogic hallucinations: Vivid, often frightening, dream-like experiences that occur during the transition from wakefulness to sleep (hypnagogic) or, less commonly, upon awakening (hypnopompic).
Multiple narcoleptic phenotypes are distinguished by their specific symptom profiles and the presence or absence of specific biomarkers (like hypocretin deficiency or presence of cataplexy), leading to classifications such as Narcolepsy Type 1 (with cataplexy and/or hypocretin deficiency) and Narcolepsy Type 2 (without